# Functionally Validated Structural Endpoints for Early AMD

> **NCT04112667** · — · COMPLETED · sponsor: **Cynthia Owsley** · enrollment: 556 (actual)

## Conditions studied

- Age-related Macular Degeneration
- Aging

## Interventions

- **OTHER:** Normal Macular Health
- **OTHER:** Early Macular Degeneration
- **OTHER:** Young Normals

## Key facts

- **NCT ID:** NCT04112667
- **Lead sponsor:** Cynthia Owsley
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-07
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-10-31
- **Target enrollment:** 556 (ACTUAL)
- **Last updated:** 2025-09-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04112667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04112667, "Functionally Validated Structural Endpoints for Early AMD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04112667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*